This result suggests that the AC of Tn/Tm changes more markedly than the percentage as the disease progresses in NSCLC, and the AC of CD4+ Tn and CD8+ Tn showed a decline in change (Table 2). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.